Skip to Navigation
Universities Allied for Essential Medicines
Our drugs. Our labs. Our responsibility.
Login | Register
  • Our issues
    • Overview
    • Background: medical R&D
    • Background: patents
    • The research gap
    • The access gap
    • Bibliography
    • Glossary
    • Learn more
  • Our work
    • Proposals and projects
    •    University tech transfer
      • Global access licensing
      • Technology transfer metrics
      • UC campaign
    •    Neglected disease research
      • Overview
      • ND-Innovation Symposium
      • Patent pools
    •    National legislation
      • USA
      • Canada
      • Bayh-Dole Act analogues
        • Take Action
    •    International agreements
    •    Student empowerment
    • Successes
    • Publications
    • Documents
    • FAQ
  • Get involved
    • Add your voice (PCS)
    • Jobs and Internships
    • Annual conference
      • 2011: JHU & UMBC
        • Registration
      • 2010: UNC & Duke
      • 2009: Yale
      • 2008: Berkeley
      • 2007: Harvard
      • 2006: Pennsylvania
    • Global Access to Medicines Month
    • Mailing list
    • Academic network
    • Alumni network
    • Buy a T-shirt
  • About us
    • Vision, mission, values
    • History
    • Student leaders
    • Board of Directors
    • Advisory Board
    • Our supporters
    • Contact us
  • Chapters
    • Find your local chapter
    • About starting a chapter
    • Register a chapter
    • Outreach coordinators
    • Resources
    • Event Report
    • Annual chapter update
  • News
    • Archive
    • Events
    • Newsletter
    • Blog
    • Media coverage
  • DONATE
Home › Our work › Projects › National legislation

National legislation

USA: generic biologics legislation and Bill S4040

Canada: implementation of WTO August 30 2003 decision

Bayh-Dole Act analogues in India and South Africa

  • USA legislation
  • Canadian legislation
  • Bayh-Dole Act analogues
‹ Patent pools up USA legislation ›
  • Printer-friendly version
  • PDF version

Our work

  • Projects
    • University technology transfer
    • Neglected disease research
    • National legislation
      • USA legislation
      • Canadian legislation
      • Bayh-Dole Act analogues
    • Bayh-Dole and Analogues
    • International agreements
    • Student empowerment
  • Successes
  • UAEMer-authored publications
  • Frequently asked questions

Get connected


Follow UAEM on Twitter
Donate now to support our work

Copyright 2010 Universities Allied for Essential Medicines. This work is licensed under a Creative Commons BY-NC-SA 2.5 License. Site design and maintenance by Matt Reimer.